Excess mortality due to tuberculosis and factors associated to death in an annual cohort of patients diagnosed of tuberculosis;Exceso de mortalidad por tuberculosis y factores asociados a la defunción en una cohorte anual de enfermos diagnosticados de tuberculosis

Revista Clinica Espanola

Volumn 206, Issue 11, 2006, Pages 560-565

  Pina, J M ^a,h   Dominguez A ^b   Alcaide, J ^c   Alvarez J ^d   Camps, N ^d   Diez M ^e   Godoy, P ^d   Jansa J M ^f   Minguell, S ^d   Arias, C ^g  

^a Programa de la Tuberculosi de la Regió Sanitària Centre de Catalunya   (Spain)

^b Departament de Sanitat i Seguretat Social   (Spain)

^c GENERALITAT DE CATALUNYA   (Spain)

^d Departamento de Sanitat i Seguretat Social de Catalunya   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f INSTITUT CATALÀ DE LA SALUT   (Spain)

^g Unidad de Vigilancia Epidemiológica de la Región Sanitaria Centro de Cataluña   (Spain)

^h NONE   (Spain)

Author keywords

Tuberculosis; Tuberculosis mortality

Indexed keywords

ALCOHOLISM; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MEDICAL RECORD; MORTALITY; NEOPLASM; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SPAIN; SUBSTANCE ABUSE; SURVIVAL; TUBERCULOSIS;

EID: 33845923915     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(06)72897-1     Document Type: Article

References (22)

1. Dut AK, Stead WW. Epidemiology and Host Factors. En: Schlossberg D, editor. Tuberculosis and Nontuberculous Mycobacterial Infections. 4th ed. Philadelphia: Saunders; 1999. p. 3-17
2. Maher D, Raviglione MC. The global epidemic of tuberculosis: a World Health Organization perspective. En: Schlossberg, editor. Tuberculosis and Nontuberculous Mycobacterial infections. Philadelphia: Saunders; 1999. p. 104-15.
3. st ed. International Union Against Tuberculosis and Lung Disease. Paris; 1999. p. 123-31.
4. Cullinan T, Meredith SK. Deaths in adults with notified pulmonary tuberculosis 1983-5. Thorax. 1991;46:347-50.
5. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N. Mortality among tuberculosis patients in the Netherlands in the period 1993-1995. Eur Respir J. 1998;11:816-20
6. Rao VK, Iademarco EP, Fraser VJ, Kollef M. The impact of Comorbidity on Mortality Following In-hospital of Tuberculosis. Chest. 1998;114:1244-52.
7. Hansel NN, Merriman B, Haponik EF, Diette GB. Hospitalizations for tuberculosis in the United States in 2000. Predictors of in-hospital mortality. Chest. 2004;126:1079-86.
8. Díez M, Hernández JA, Caloto T, Catells C, Domínguez A, García AM, et al, for the PMIT Working Group. Resultados del tratamiento antituberculoso en seis comunidades autónomas españolas. Med Clin (Barc). 2001;117:474-80.
9. World Health Organization (WHO). International Union Against Tuberculosis and Lung Disease (IUATLD). Royal Netherlands Tuberculosis Association (KNCV). Revised international definitions in tuberculosis control. Int Tuberc Lung Dis. 2001;5(3):213-5.
10. Registre de Mortalitat de Catalunya i registre d'Interrupcions Voluntàries de l'Embaràs, Servei d'Informació i Estudis, Direcciò General de Recursos Sanitaris, Departament de Salut de la Generalitat de Catalunya. Elaboració pròpia; 2005
11. American Thoracic Society/Centres for Disease Control and Prevention/ Infectious Diseases Society of America: Treatment of Tuberculosis. Am J Respir Crit Care Med. 2003;167:603-62.
12. PozsiK CJ. Compliance with tuberculosis therapy. Med Clin North Am. 1993;77(6):1289-301.
13. Pablos-Méndez A, Sterling TR, Frieden TR. The Relationship Between Delayed or Incomplete Treatment and All-Cause Mortality in Patients With Tuberculosis. JAMA. 1996;276:1223-8.
14. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001;33:1034-9.
15. Pérez-Guzmán C, Vargas MH, Torres-Cruz A, Villareal-Velarde H. Does aging modify pulmonary tuberculosis? A meta-analytical review. Chest. 1999;116:961-7.
16. Datta M, Radhaman MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudeendra CR, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the direct tuberculosis programme. Tubercle Lung Dis. 1993;74:180-6.
17. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P. Human Inmunodefiency Virus and the Outcome of Treatment for New and Recurrent Pulmonary Tuberculosis in Africa Patiens. Am J Respir Crit Care Med. 1999;159:733-40.
18. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-21.
19. Kwara A, Flanigan TP, Carter EJ. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status. Int J Tuberc Lung Dis. 2005;9(3):248-57.
20. Ellard GA. Chemotherapy of tuberculosis for patients with renal impairment. Nephron. 1993;64:169-81.
21. Homrany MAI. Sucessful therapy of tuberculosis in hemodialysis patients. Am J Nephrol. 1997;17:32-5.
22. Quantrill SJ, Woodhead MA, Bell CE, Ardi CC, Hutchinson AJ, Gomal R. Side-effects of antituberculosis drug treatment in patients with chronic renal failure. Eur Respir J. 2002;20:440-3.